Position in LGND
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$114,434,786
+$20,625,816 QoQ
Shares Held
573,177
+15.5% QoQ
Ownership
2.86%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 99.88014173632229.ToString("F0")%
Shared 0.ToString("F0")%
None 0.11985826367771212.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. LGND ranks #11 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in LGND
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $114,434,786 | 573,177 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $93,808,970 | 496,160 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $40,716,690 | 229,856 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $21,155,733 | 186,099 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $19,593,574 | 186,357 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $19,865,822 | 185,402 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $9,474,418 | 94,659 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $1,321,701 | 15,686 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,018,940 | 13,939 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $1,004,592 | 14,066 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $816,587 | 13,628 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $680,406 | 9,437 | Shares | Defined | 2023-08-11 | |
| 2022-06-30 | $126,620 | 2,275 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $180,488 | 2,572 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $244,840 | 2,541 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $204,154 | 2,349 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $127,505 | 1,558 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $138,658 | 1,458 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||